You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 20, 2025

Details for Patent: 9,192,590


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,192,590 protect, and when does it expire?

Patent 9,192,590 protects PROCYSBI and is included in two NDAs.

Protection for PROCYSBI has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-nine patent family members in nineteen countries.

Summary for Patent: 9,192,590
Title:Enterically coated cysteamine, cystamine and derivatives thereof
Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
Inventor(s): Dohil; Ranjan (San Diego, CA), Schneider; Jerry (La Jolla, CA)
Assignee: The Regents of the University of California (Oakland, CA)
Application Number:14/752,499
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,192,590
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery; Dosage form; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,192,590

Introduction

Understanding the scope and claims of a patent is crucial for determining its value, identifying potential infringements, and strategizing intellectual property protection. This article will delve into the details of United States Patent 9,192,590, exploring its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 9,192,590 is listed in the FDA Orange Book Drug Database, indicating its relevance to pharmaceuticals. Here, we will break down the key components of this patent.

Claims Analysis

Claim Structure

Patent claims are the most critical part of any patent application, as they define the scope of the invention and what is protected by the patent. For US Patent 9,192,590, the claims would typically be categorized into independent and dependent claims.

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. They are crucial for understanding the core of what the patent protects.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or limitations. They help in narrowing down the scope and often add specificity to the invention[3].

Claim Coverage Matrix

To analyze the claims effectively, a Claim Coverage Matrix can be used. This matrix helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist. By categorizing claims by scope concepts, it becomes easier to filter, search, and analyze large numbers of patent claims concurrently[3].

Scope of the Patent

Technological Domain

The scope of US Patent 9,192,590 is tied to its technological domain, which in this case appears to be related to pharmaceuticals. Understanding the specific technology or method protected by the patent is essential for determining its applicability and potential infringements.

Geographic Scope

The patent's geographic scope is limited to the United States, but its impact can be global if similar patents are filed in other jurisdictions. International patent offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) can provide insights into whether similar patents exist or are being pursued in other countries[1].

Patent Landscape Analysis

Competitor Patents

Analyzing the patent landscape involves identifying similar patents held by competitors. This can be done using tools like the Patent Public Search tool provided by the USPTO or international databases such as esp@cenet and PATENTSCOPE®. By comparing the claims and scope of US Patent 9,192,590 with those of competitor patents, one can identify potential overlaps, gaps, or opportunities for innovation[1].

Patent Family

The Global Dossier service provided by the USPTO allows users to see the patent family for a specific application, including all related applications filed at participating IP Offices. This helps in understanding the broader patent family and how US Patent 9,192,590 fits into it[1].

Valuation of the Patent

Valuation Methods

The value of a patent can be determined using three primary methods: cost, income, and market.

  • Cost Approach: This method considers the replacement cost or the cost incurred in developing the patent.
  • Income Approach: This method evaluates the future benefits provided by the patent, such as income or savings, and calculates their present value.
  • Market Approach: This method determines the value based on what a willing buyer would pay for a similar asset, using sales and asking price data[4].

Practical Applications and Future Directions

Claim Charts

Using ClaimScape® software or similar tools, interactive claim charts can be generated to help engineers, scientists, and management review the patent coverage. These charts are useful for identifying gaps in current coverage and highlighting future design opportunities[3].

Strategic Decision-Making

Understanding the scope and claims of US Patent 9,192,590 enables strategic decision-making. For instance, if the patent covers a high-value scope concept, it may be crucial to maintain and enforce it. Conversely, if the scope concept is deemed low-value, it might be considered for abandonment or licensing[3].

Regulatory and Legal Considerations

FDA Orange Book

Since US Patent 9,192,590 is listed in the FDA Orange Book, it is subject to regulatory oversight. The FDA Orange Book provides information on approved drugs, including their associated patents and expiration dates. This is critical for pharmaceutical companies to ensure compliance and plan their product strategies[2].

International Compliance

Compliance with international intellectual property laws is also essential. Tools like the Common Citation Document (CCD) and Global Dossier help in navigating the global patent landscape and ensuring that the patent is aligned with international standards[1].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the patent.
  • Scope and Technological Domain: The patent's scope is tied to its technological domain, which in this case is pharmaceuticals.
  • Patent Landscape: Analyzing competitor patents and the broader patent family helps in identifying opportunities and gaps.
  • Valuation: The value of the patent can be determined using cost, income, and market approaches.
  • Practical Applications: Claim charts and strategic decision-making tools are essential for managing the patent effectively.
  • Regulatory Compliance: Ensuring compliance with FDA regulations and international intellectual property laws is vital.

FAQs

Q: What is the primary purpose of analyzing the claims of a patent? A: The primary purpose is to define the scope of the invention and understand what is protected by the patent.

Q: How can the Global Dossier service help in patent analysis? A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family and related applications.

Q: What are the three main methods for valuing a patent? A: The three main methods are the cost approach, income approach, and market approach.

Q: Why is it important to list a patent in the FDA Orange Book? A: Listing in the FDA Orange Book provides information on approved drugs and their associated patents, which is critical for regulatory compliance and strategic planning.

Q: How can claim charts be used in patent management? A: Claim charts can be used to review patent coverage with technical experts, identify gaps in current coverage, and highlight future design opportunities.

Sources

  1. USPTO - Search for patents
  2. PharmaCompass - US Patent 9192590
  3. SLWIP - Patent Analytics
  4. Perpetual Motion Patents - The value of a patent

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,192,590

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Horizon PROCYSBI cysteamine bitartrate CAPSULE, DELAYED RELEASE;ORAL 203389-001 Apr 30, 2013 RX Yes No 9,192,590*PED ⤷  Try for Free Y ⤷  Try for Free
Horizon PROCYSBI cysteamine bitartrate CAPSULE, DELAYED RELEASE;ORAL 203389-002 Apr 30, 2013 RX Yes Yes 9,192,590*PED ⤷  Try for Free Y ⤷  Try for Free
Horizon PROCYSBI cysteamine bitartrate GRANULE, DELAYED RELEASE;ORAL 213491-001 Feb 14, 2020 RX Yes No 9,192,590*PED ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 3 of 3 entries

International Family Members for US Patent 9,192,590

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 1919458 ⤷  Try for Free C300649 Netherlands ⤷  Try for Free
European Patent Office 1919458 ⤷  Try for Free CR 2014 00013 Denmark ⤷  Try for Free
European Patent Office 1919458 ⤷  Try for Free 194 50001-2014 Slovakia ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.